Predictors of Clinical Response in Patients with High Risk Acute Myeloid Leukemia Receiving Treatment with the Histone Deacetylase Inhibitor Sodium Valproate.
暂无分享，去创建一个
C. Bradbury | C. Bunce | C. Craddock | B. Turner | D. Grimwade | S. Basu | M. Griffiths | A. Sawers | A. Rye | M. Cook | S. Narayanan | A. Macwhannell